Why do eyes get red when high

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Eyes get red when high primarily due to cannabis-induced vasodilation, which expands blood vessels in the conjunctiva, increasing blood flow and causing visible redness. This effect typically begins within minutes of consumption and can last 2-6 hours depending on dosage and individual metabolism. According to a 2018 study in the Journal of Clinical Pharmacology, approximately 45% of cannabis users experience noticeable eye redness. The redness is generally harmless and resolves without intervention as THC metabolites clear from the system.

Key Facts

Cannabis causes vasodilation in ocular blood vessels within 5-30 minutes of consumption
Eye redness typically lasts 2-6 hours depending on THC dosage and individual factors
Approximately 45% of cannabis users experience noticeable eye redness according to 2018 research
THC binds to CB1 receptors in the eye, reducing blood pressure and increasing blood flow
Redness is most prominent in the conjunctiva where blood vessels are closest to the surface

Overview

Red eyes from cannabis use have been documented since ancient times, with Chinese medical texts from 2737 BCE describing cannabis preparations that caused "bloodshot eyes." The phenomenon became widely recognized in Western medicine during the 19th century as cannabis extracts entered pharmacopeias. In modern times, with cannabis legalization expanding globally since Uruguay's 2013 legalization and Canada's 2018 nationwide legalization, understanding this side effect has gained renewed importance. According to the 2021 National Survey on Drug Use and Health, approximately 52.5 million Americans reported using cannabis in the past year, making eye redness a common concern. The condition is medically termed "cannabis-induced conjunctival hyperemia" and represents one of the most visible physiological effects of THC consumption, often serving as an informal indicator of recent use in social and medical contexts.

How It Works

The mechanism involves THC (tetrahydrocannabinol) binding to CB1 receptors in the eye's vascular system, particularly in the conjunctiva—the clear membrane covering the white part of the eye. This binding triggers vasodilation through several pathways: it reduces sympathetic nervous system activity, decreases norepinephrine release, and activates endothelial nitric oxide synthase, which produces nitric oxide that relaxes blood vessel walls. The resulting expansion increases blood flow by approximately 30-50% to ocular tissues, making normally microscopic capillaries visible as red lines. Additionally, THC lowers intraocular pressure by about 25-30%, which contributes to the vascular changes. The effect is dose-dependent, with studies showing that 10mg of THC produces noticeable redness in most users, while higher doses (20mg+) cause more pronounced effects. Individual factors like tolerance, genetics affecting CB1 receptor density, and concurrent alcohol use can modify the response.

Why It Matters

Understanding cannabis-induced eye redness has practical significance in multiple domains. Medically, it helps differentiate benign cannabis effects from pathological conditions like conjunctivitis or uveitis, preventing unnecessary treatments. In workplace and roadside testing contexts, red eyes serve as a visible indicator that may prompt further screening, though they're not definitive proof of impairment. The vasodilation mechanism has therapeutic implications—pharmaceutical companies have developed synthetic cannabinoids like dronabinol that minimize this side effect while maintaining therapeutic benefits. For cannabis users, managing redness with over-the-counter eye drops containing tetrahydrozoline (which constricts blood vessels) represents a $47 million annual market in the United States alone. Furthermore, research into why cannabis reduces intraocular pressure while increasing blood flow continues to inform glaucoma treatment development, with studies showing cannabis can lower pressure by 25% for 3-4 hours.